UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gamma-delta (γδ) T cells: friend or foe in cancer development?

Journal of translational medicine, 2018-01, Vol.16 (1), p.3-13, Article 3

2018

Volltextzugriff (PDF)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Biomarker research, 2020-08, Vol.8 (1), p.34-34, Article 34

2020

Volltextzugriff (PDF)

Advances and applications of RNA vaccines in tumor treatment

Molecular cancer, 2024-10, Vol.23 (1), p.226-12, Article 226

2024

Volltextzugriff (PDF)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

Frontiers in immunology, 2022-06, Vol.13, p.890166-890166

2022

Volltextzugriff (PDF)

Mechanisms of Cancer Resistance to Immunotherapy

Frontiers in oncology, 2020-08, Vol.10, p.1290-1290

2020

Volltextzugriff (PDF)

Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy

Frontiers in immunology, 2022-05, Vol.13, p.886931-886931

2022

Volltextzugriff (PDF)

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

Journal of experimental & clinical cancer research, 2019-09, Vol.38 (1), p.403-403, Article 403

2019

Volltextzugriff (PDF)

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Chinese medical journal, 2024-01, Vol.137 (2), p.130-139

2024

Volltextzugriff (PDF)

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Journal of cancer research and clinical oncology, 2022, Vol.148 (1), p.163-176

2022

Volltextzugriff (PDF)

Anaplastic lymphoma kinase-special immunity and immunotherapy

Frontiers in immunology, 2022-07, Vol.13, p.908894

2022

Volltextzugriff (PDF)

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

International journal of cancer, 2014-01, Vol.134 (2), p.342-351

2014

Volltextzugriff (PDF)

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Current cancer drug targets, 2021-01, Vol.21 (2), p.117-131

2021

Volltextzugriff (PDF)

Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives

Cancer biology & medicine, 2022-10, Vol.19 (12), p.1-13

2022

Volltextzugriff (PDF)

Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy

Frontiers in oncology, 2022-01, Vol.11, p.724424-724424

2022

Volltextzugriff (PDF)

Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria

Cancer letters, 2023-06, Vol.564, p.216223-216223, Article 216223

2023

Volltextzugriff (PDF)

Anti-angiogenesis: Opening a new window for immunotherapy

Life sciences (1973), 2020-10, Vol.258, p.118163-118163, Article 118163

2020

Volltextzugriff (PDF)

Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy

Frontiers in immunology, 2022-12, Vol.13, p.1074906-1074906

2022

Volltextzugriff (PDF)

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Journal of translational medicine, 2023-02, Vol.21 (1), p.108-108, Article 108

2023

Volltextzugriff (PDF)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?

Frontiers in oncology, 2020-07, Vol.10, p.912-912

2020

Volltextzugriff (PDF)

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231187205-17588359231187205

2023

Volltextzugriff (PDF)

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

Oncology letters, 2018-10, Vol.16 (4), p.4105-4113

2018

Volltextzugriff (PDF)

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6855-n/a

2024

Volltextzugriff (PDF)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003214

2021

Volltextzugriff (PDF)

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC

Thoracic cancer, 2022-10, Vol.13 (19), p.2799-2807

2022

Volltextzugriff (PDF)

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”

Journal of Immunology Research, 2022-07, Vol.2022, p.1-2

2022

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

SpracheJapanisch

ThemaImmunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gamma-delta (γδ) T cells: friend or foe in cancer development?

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Advances and applications of RNA vaccines in tumor treatment

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing

Mechanisms of Cancer Resistance to Immunotherapy

Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Anaplastic lymphoma kinase-special immunity and immunotherapy

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives

Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy

Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria

Anti-angiogenesis: Opening a new window for immunotherapy

Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Present and future of cancer immunotherapy: A tumor microenvironmental perspective

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”

Aktive Filter

Suchergebnisse filtern